Scott Hazelwood's questions to Biostem Technologies Inc (BSEM) leadership • Q2 2024
Question
Scott Hazelwood requested more specific details about the next steps and timeline for the company's Form 10 filing and planned uplisting to the NASDAQ.
Answer
Executive Michael Fortunato explained that BioStem is currently updating its registration table with Q2 numbers. The NASDAQ application has been filed and is pending SEC review of the Form 10. He expressed hope that the process would be completed in 'relatively short order,' estimating a timeline of the next 60 to 90 days.